ATE323719T1 - Hla-a2 beschränktes tumorantigen-peptid, das von sart-1 abstammt - Google Patents

Hla-a2 beschränktes tumorantigen-peptid, das von sart-1 abstammt

Info

Publication number
ATE323719T1
ATE323719T1 AT99931554T AT99931554T ATE323719T1 AT E323719 T1 ATE323719 T1 AT E323719T1 AT 99931554 T AT99931554 T AT 99931554T AT 99931554 T AT99931554 T AT 99931554T AT E323719 T1 ATE323719 T1 AT E323719T1
Authority
AT
Austria
Prior art keywords
tumor antigen
antigen peptide
sart
hla
peptide derived
Prior art date
Application number
AT99931554T
Other languages
English (en)
Inventor
Kyogo Itoh
Terutada Kobayashi
Original Assignee
Greenpeptide Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Greenpeptide Co Ltd filed Critical Greenpeptide Co Ltd
Application granted granted Critical
Publication of ATE323719T1 publication Critical patent/ATE323719T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT99931554T 1998-07-28 1999-07-27 Hla-a2 beschränktes tumorantigen-peptid, das von sart-1 abstammt ATE323719T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP21294098 1998-07-28

Publications (1)

Publication Number Publication Date
ATE323719T1 true ATE323719T1 (de) 2006-05-15

Family

ID=16630822

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99931554T ATE323719T1 (de) 1998-07-28 1999-07-27 Hla-a2 beschränktes tumorantigen-peptid, das von sart-1 abstammt

Country Status (12)

Country Link
US (1) US6664232B1 (de)
EP (1) EP1103561B1 (de)
KR (1) KR20010071033A (de)
CN (1) CN1262562C (de)
AT (1) ATE323719T1 (de)
AU (1) AU765733B2 (de)
CA (1) CA2336486A1 (de)
DE (1) DE69930942D1 (de)
HK (1) HK1039946A1 (de)
ID (1) ID27162A (de)
NZ (1) NZ509585A (de)
WO (1) WO2000006595A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080254445A1 (en) * 2003-09-22 2008-10-16 Kyogo Itoh Prognosis in Cancer Patients Vaccinated with a Cancer Antigen Peptide-Associated Agent
CN101434647A (zh) * 2004-01-20 2009-05-20 爱知县 由HLA-A2402-限制的Ep-CAM-特异的CTL识别的表位/肽及其应用
CN101888852B (zh) * 2007-12-05 2017-02-08 株式会社癌免疫研究所 癌症疫苗组合物
TW201008574A (en) 2008-08-19 2010-03-01 Oncotherapy Science Inc INHBB epitope peptides and vaccines containing the same
CA2741399C (en) 2008-10-22 2016-10-11 Oncotherapy Science, Inc. Rab6kifl/kif20a epitope peptide and vaccines containing the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992009715A1 (en) 1990-11-21 1992-06-11 Leningradskaya Assotsiatsia 'poliplazma' Method for plasma jet spraying of biologically active coatings on an implant
US5554724A (en) * 1994-03-24 1996-09-10 University Of Leiden Isolated tumor rejection antigen precursor MAGE-2 derived peptides, and uses thereof
CN1203177C (zh) 1996-06-07 2005-05-25 伊东恭悟 肿瘤抗原蛋白质及其基因和肿瘤抗原肽
EP1055684A4 (de) 1997-12-05 2002-12-04 Kyogo Itoh Tumorantigene in form von peptidderivaten
EP1097940A1 (de) 1998-07-10 2001-05-09 Kyogo Itoh Tumorantigen-peptid, das von sart-1 abstammt.

Also Published As

Publication number Publication date
ID27162A (id) 2001-03-08
CN1310723A (zh) 2001-08-29
WO2000006595A1 (fr) 2000-02-10
CA2336486A1 (en) 2000-02-10
DE69930942D1 (de) 2006-05-24
NZ509585A (en) 2003-05-30
HK1039946A1 (zh) 2002-05-17
EP1103561B1 (de) 2006-04-19
AU4801699A (en) 2000-02-21
KR20010071033A (ko) 2001-07-28
US6664232B1 (en) 2003-12-16
AU765733B2 (en) 2003-09-25
EP1103561A4 (de) 2002-03-27
EP1103561A1 (de) 2001-05-30
CN1262562C (zh) 2006-07-05

Similar Documents

Publication Publication Date Title
CY1114164T1 (el) Μεθοδος ελεγχου της δραστικοτητας ανοσολογικα λειτουργικου μοριου
DE69937294D1 (de) Von cyclophilin b abstammende tumorantigen-peptide
CY1109699T1 (el) Νουκλεινικα οξεα που κωδικοποιουν πολυπεπτιδια πολυεπιτοπων
DE3888086D1 (de) Rekombinantes Geflügelpockenvirus, Expressionsvektoren für heterologische Proteine und davon derivierte Geflügelvakzine.
DK0668350T4 (da) Melanomassocieret antigen, epitoper deraf samt vacciner mod melanom
ATE136908T1 (de) Peptide und antikörper, die die integrin- ligandbindung inhibieren
CY1105446T1 (el) Διαγνωση και θepαπεια διαταραχων που συνδεονται με aur1 και aur2
EA200101037A1 (ru) Соединения и способы для лечения и диагностики рака легкого
ITTO950367A0 (it) Proteine di prrsv ricombinanti, corredi diagnostici e vaccini contenenti tali proteine di prrsv ricombinanti.
TR200003347T2 (tr) Neisseria meningitidis'denBASB029 polinükleotidleri ve polipeptidler
DE69935220D1 (de) Von menschlichem tumor stammendes polypeptidhormon phosphatonin
DE69930942D1 (de) Hla-a2 beschränktes tumorantigen-peptid, das von sart-1 abstammt
ATE412747T1 (de) Neues tumor-antigen-protein sart-3 und tumor- antigen-peptid davon
ATE464383T1 (de) Tumor antigen
CY1105820T1 (el) Basb027 πρωτεϊνες και γονιδια απο moraxella catarrhalis, αντιγονα, αντισωματα και χρησεις
WO2001029220A3 (en) Mage-a12 antigenic peptides and uses thereof
BR9911601A (pt) Polipeptìdios antigênicos de neisseria meningitidis, polinucleotìdeos correspondentes e anticorpos protetores
ITRM920506A1 (it) Regioni antigeniche dei complessi tpl e anticorpi diretti contro di essi.
TR200000416T2 (tr) Neisseria loctoferrin bağlayıcı protein.
ATE354657T1 (de) Basb019 proteine und gene aus moraxella catarrhalis, antigene, antikörper, und verwendungen
ATE281524T1 (de) Moraxella catarrhalis pilq proteine
PT854727E (pt) Antigenios de rejeicao tumoral apresentados pelas moleculas b44-alh e suas utilizacoes
DE60019614D1 (de) Moraxella catarrhalis antigen basb117
DE60019613D1 (de) Moraxella catarrhalis antigen basb120

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties